US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALLURION TECHNOLOGIES

2.33

-0.0400-1.69%

Volume:41.04K

Turnover:96.28K

Market Cap:13.90M

PE:-0.20

High:2.45

Open:2.32

Low:2.29

Close:2.37

Loading ...

Overview Company News Filings

Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump

MT Newswires Live

BUZZ-Allurion Technologies rises on initial data from weight-loss device treatment

Allurion announces initial results from Allurion Program-GLP-1 combo

Allurion Technologies Inc - Average Total Weight Loss of 20% With 15% Increase in Lean Body Mass After 8 Months of Combined Therapy

THOMSON REUTERS

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-Dose Glp-1 Therapy to Optimize Muscle Mass and Glp-1 Adherence

THOMSON REUTERS

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Calendar of U.S. Earnings Expected in the Week Ahead

Roth MKM Reaffirms Their Buy Rating on Allurion Technologies (ALUR)

Allurion Technologies price target lowered to $16 on split-adjusted basis

Allurion Technologies announces issuance of new patents on weight loss device

BRIEF-Allurion Announces Notification Of Issuance Of New U.S. Patents On Next-Generation Weight Loss Device For The Treatment Of Obesity

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

THOMSON REUTERS

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion to Participate in Upcoming Investor Conferences

Nyse Halt Allurion Tch Ord Add Info Lst $3.480000

THOMSON REUTERS

BUZZ-Allurion Tech dips on $6.1 million stock offering

S&P 500 Edges Higher; Analog Devices Earnings Top Views

Allurion Technologies Expects to Raise $6.1 Million From Stock Offering; Shares Plunge

MT Newswires Live

BRIEF-Allurion To Raise Approximately $6.1 Million Of Gross Proceeds In Offering And Concurrent Private Placement To Advance Glp-1 Clinical Pipeline

Allurion to sell 900,000 shares at $5.23 in registered direct offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALUR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALUR\",,,,,undefined,":{"symbol":"ALUR","market":"US","secType":"STK","nameCN":"ALLURION TECHNOLOGIES","latestPrice":2.33,"timestamp":1746129600000,"preClose":2.37,"halted":0,"volume":41040,"delay":0,"floatShares":3983697,"shares":5963549,"eps":-11.635999,"marketStatus":"Pre-Mkt","change":-0.04,"latestTime":"05-02 05:43:33 EDT","open":2.32,"high":2.4499,"low":2.29,"amount":96284.68272000001,"amplitude":0.067468,"askPrice":2.64,"askSize":100,"bidPrice":2.08,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-11.635999,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746192600000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":2.33,"postHourTrading":{"tag":"盘后","latestPrice":2.33,"preClose":2.33,"latestTime":"19:44 EDT","volume":65,"amount":155.15,"timestamp":1746143067613},"volumeRatio":1.3052576739237443,"impliedVol":0.5858,"impliedVolPercentile":0.256},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALUR\",,,,,undefined,":{"symbol":"ALUR","floatShares":3983697,"roa":"-54.05%","roe":"--","lyrEps":-11.635999,"volumeRatio":1.3052576739237443,"shares":5963549,"dividePrice":0,"high":2.4499,"amplitude":0.067468,"preClose":2.37,"low":2.29,"week52Low":2.15,"pbRate":"-0.18","psRate":"0.43","week52High":88.75,"institutionHeld":0,"latestPrice":2.33,"eps":-11.635999,"divideRate":0,"volume":41040,"delay":0,"ttmEps":-11.635999,"open":2.32,"prevYearClose":10.75,"prevWeekClose":2.4,"prevMonthClose":2.37,"prevQuarterClose":3.21,"fiveDayClose":2.33,"twentyDayClose":3.35,"sixtyDayClose":6.39},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALUR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521494281","title":"Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2521494281","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521494281?lang=en_us&edition=fundamental","pubTime":"2025-03-21 05:16","pubTimestamp":1742505373,"startTime":"0","endTime":"0","summary":"Allurion Technologies  said Thursday that initial trial results from the Allurion balloon in combination with semaglutide showed total body weight loss and lean body mass gains.The company treated 52 patients in the study and the average total body weight loss was 20.3% after eight months while the lean body mass increased by 15%, according to the company.Shares of the company were up 29% in recent after-hours activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4192","ALUR"],"gpt_icon":1},{"id":"2521249130","title":"BUZZ-Allurion Technologies rises on initial data from weight-loss device treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2521249130","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521249130?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:41","pubTimestamp":1742503315,"startTime":"0","endTime":"0","summary":"BUZZ-Allurion Technologies rises on initial data from weight-loss device treatment ** Shares of healthcare company Allurion Technologies > rise 25% to $2.85 in aftermarket trade ** Company says initial data shows patients treated with its device along with low doses of Novo Nordisk's NOVOb.CO semaglutide resulted in average total body weight loss of 20.3% and lean body mass increase to 68.5%** Company's device called Allurion Balloon occupies space in the stomach and is designed to promote satiety and reduce food consumption     ** The balloon is non-surgical, swallowed and is designed to naturally empty and be eliminated about 4 months later - ALUR ** Company says all 52 patients remained adherent to the GLP-1 medication through eight months** Additional data on the combination approach is being collected and is expected to be presented at upcoming medical meetings - company** Stock had fallen 88.5% in 2024   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL4N3Q31L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2521326499","title":"Allurion announces initial results from Allurion Program-GLP-1 combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2521326499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521326499?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:15","pubTimestamp":1742501755,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize muscle ma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-announces-initial-results-from-allurion-program-glp-1-combo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-announces-initial-results-from-allurion-program-glp-1-combo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4144","ALUR","BK4192","GLP","BK4590"],"gpt_icon":0},{"id":"2521496998","title":"Allurion Technologies Inc - Average Total Weight Loss of 20% With 15% Increase in Lean Body Mass After 8 Months of Combined Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2521496998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521496998?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:05","pubTimestamp":1742501100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA1TWTMN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2521496976","title":"Allurion Announces Initial Results on the Combination of the Allurion Program With Low-Dose Glp-1 Therapy to Optimize Muscle Mass and Glp-1 Adherence","url":"https://stock-news.laohu8.com/highlight/detail?id=2521496976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521496976?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:05","pubTimestamp":1742501100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA1TWTMN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2521915314","title":"Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence","url":"https://stock-news.laohu8.com/highlight/detail?id=2521915314","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521915314?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:05","pubTimestamp":1742501100,"startTime":"0","endTime":"0","summary":"Average Total Weight Loss of 20% With 15% Increase in Lean Body Mass After 8 Months of Combined Therapy. \"I believe combining the Allurion Balloon with low-dose GLP-1 therapy has several advantages,\" said Dr. Luigi Flagiello, bariatric surgeon at Clinica Ruesch who oversaw this case series. \"These results indicate that a combination approach increases weight loss and that by using lower doses of GLP-1s, patients do not experience as many side effects—including muscle wasting—and have improved adherence. Patients may also be benefiting from two distinct physiological impacts: satiety induction from the balloon and reduced hunger from the GLP-1.\". Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, ProcedurelessTM gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare provide","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allurion-announces-initial-results-combination-200500111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4192","ALUR","BK4144","GLP","BK4590"],"gpt_icon":0},{"id":"2520439968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439968?lang=en_us&edition=fundamental","pubTime":"2025-03-20 18:00","pubTimestamp":1742464800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Amprius Tech Inc                                4Q      (.11)  4:05 PM. ·Lands' End Inc.                                   4Q       .57   6:45 AM. ·Lennar Corp Class A                              1Q      1.70       AMC","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMC","TELA","NKTX","DERM","LVTX","MNSO","JEF","NKE","PAYX","FLUX","SPRY","MBRX","JKS","ACRV","KLC","PL","WOR","CURV","GDEV","IFRX","THRD","ALUR","BRNS","CDLR","FBRX","OUST","SLS","RLMD","BCAB","SBS","LEN","MLKN","BBNX","TITN","TH","COYA","MGNX","CBUS","LPTX","MREO","ASO","RUM","DRI","SOWG","BLRX","BRAG","SKYE","CELC"],"gpt_icon":1},{"id":"2517193706","title":"Roth MKM Reaffirms Their Buy Rating on Allurion Technologies (ALUR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517193706?lang=en_us&edition=fundamental","pubTime":"2025-03-07 01:28","pubTimestamp":1741282102,"startTime":"0","endTime":"0","summary":"In a report released today, Jason Wittes from Roth MKM maintained a Buy rating on Allurion Technologies (ALUR – Research Report), with a price targ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-allurion-technologies-alur?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-allurion-technologies-alur?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALUR"],"gpt_icon":0},{"id":"2517905668","title":"Allurion Technologies price target lowered to $16 on split-adjusted basis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517905668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517905668?lang=en_us&edition=fundamental","pubTime":"2025-03-06 10:50","pubTimestamp":1741229448,"startTime":"0","endTime":"0","summary":"Roth MKM lowered the firm’s price target on Allurion Technologies (ALUR) to $16 from $50 and keeps a Buy rating on the shares. The firm is updating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-price-target-lowered-to-16-on-split-adjusted-basis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-price-target-lowered-to-16-on-split-adjusted-basis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2517981062","title":"Allurion Technologies announces issuance of new patents on weight loss device","url":"https://stock-news.laohu8.com/highlight/detail?id=2517981062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517981062?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:27","pubTimestamp":1741123656,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) “announced that it has received two Issue Notifications from the U.S. Patent and Trademark Office dated February 19, 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-announces-issuance-of-new-patents-on-weight-loss-device?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-announces-issuance-of-new-patents-on-weight-loss-device?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2517989334","title":"BRIEF-Allurion Announces Notification Of Issuance Of New U.S. Patents On Next-Generation Weight Loss Device For The Treatment Of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2517989334","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517989334?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:09","pubTimestamp":1741122599,"startTime":"0","endTime":"0","summary":"BRIEF-Allurion Announces Notification Of Issuance Of New U.S. Patents On Next-Generation Weight Loss Device For The Treatment Of ObesityMarch 4 (Reuters) - Allurion Technologies Inc ALUR.N:ALLURION AN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCCL0Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2517798676","title":"Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2517798676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517798676?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:05","pubTimestamp":1741122300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCCL0Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2517811649","title":"Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2517811649","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517811649?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:05","pubTimestamp":1741122300,"startTime":"0","endTime":"0","summary":"Patent portfolio now exceeds 60 issued patents globally. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss with the Allurion Virtual Care Suite, including the Allurion Mobile App and Connected Scale for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform. Patients on the Allurion Program lose 10-15% of their total body weight and in certain studies have been shown to increase their muscle mass.1. Shantanu Gaur, Allurion’s Founder and CEO, noted, \"With the issuance of these two patents, we now have amassed 22 issued patents in the U.S. and 64 issued patents globally. As we embark on new clinical trials that seek to combine the Allurion Balloon with GLP-1 therapy, we intend to continuously enhance the design and manufacture of the Allurion Balloon and move toward a new gold standard for the treatment of obesity.\". This press","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allurion-announces-notification-issuance-u-210500139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2514041707","title":"Allurion to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041707","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514041707?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:05","pubTimestamp":1740517500,"startTime":"0","endTime":"0","summary":"NATICK, Mass., February 25, 2025----Allurion Technologies, Inc.  , a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences.Dr. Shantanu Gaur, Founder and Chief Executive Officer, will present at 9:10 a.m. ET and host one-on-one investor meetings throughout the day on March 3, 2025, at the 45th Annual TD Cowen Healthcare Conference in Boston, Massachusetts. Dr. Gaur will also host one-on-one investor meetings at the 37th Annual Roth Conference in Dana Point, California from March 16-18, 2025.A webcast of the presentation will be available in the Events & Presentations section of Allurion’s investor relations website.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allurion-participate-upcoming-investor-conferences-210500309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2514143740","title":"Nyse Halt Allurion Tch Ord  Add Info Lst $3.480000","url":"https://stock-news.laohu8.com/highlight/detail?id=2514143740","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514143740?lang=en_us&edition=fundamental","pubTime":"2025-02-26 00:51","pubTimestamp":1740502272,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nAQN2K3E4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2512433539","title":"BUZZ-Allurion Tech dips on $6.1 million stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2512433539","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512433539?lang=en_us&edition=fundamental","pubTime":"2025-02-20 02:41","pubTimestamp":1739990517,"startTime":"0","endTime":"0","summary":"BUZZ-Allurion Tech dips on $6.1 million stock offering** Shares of weight-loss biotech firm Allurion Technologies ALUR.N fall 32.2% to $3.78** ALUR says it is raising about $6.1 mln through a stock offering and private placement** Company will sell 900,000 shares of common stock at $5.23/shr and issue warrants to purchase up to 1.8 mln shares** Offering price is at a 6.3% discount to the stock's last close** Funds will be used to advance company's clinical pipeline, including testing the effects of the Allurion Balloon and GLP-1 therapy - ALUR** Roth Capital Partners is acting as the exclusive placement agent for the offering and private placement** Company has 4.8 mln outstanding shares, with a market capitalization of $26.8 mln, according to data compiled by LSEG** Stock fell 87.8% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nL3N3PA17F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2512702438","title":"S&P 500 Edges Higher; Analog Devices Earnings Top Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2512702438","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512702438?lang=en_us&edition=fundamental","pubTime":"2025-02-20 02:29","pubTimestamp":1739989753,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43821314/s-analog-devices-earnings-top-views","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOO","NKLAQ","COMP","SPY","SEDG","ALUR","ADI","NKLA","SINT",".SPX","CNSP"],"gpt_icon":1},{"id":"2512481964","title":"Allurion Technologies Expects to Raise $6.1 Million From Stock Offering; Shares Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481964","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512481964?lang=en_us&edition=fundamental","pubTime":"2025-02-20 00:10","pubTimestamp":1739981431,"startTime":"0","endTime":"0","summary":"Allurion Technologies  said Wednesday it expects to raise roughly $6.1 million from a registered direct share offering to institutional investors.The company said it signed deals to sell 900,000 shares at $5.23 apiece to the investors. It will also issue warrants to the investors to buy up to 1.8 million shares.Allurion also said it struck a deal to sell 267,686 shares and warrants to purchase up to 535,372 shares at $5.23 per share and accompanying warrant to funds affiliated with Leavitt Equity Partners.Proceeds will be used to fund its pipeline evaluating the effects of the combination of the Allurion Balloon and GLP-1 therapy on muscle mass and long-term GLP-1 adherence, for working capital, and for general corporate purposes, the company said.The offering is expected to close on Thursday, it said.The shares were down more than 30% in recent trading.Price: 3.86, Change: -1.72, Percent Change: -30.88","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2512485217","title":"BRIEF-Allurion To Raise Approximately $6.1 Million Of Gross Proceeds In Offering And Concurrent Private Placement To Advance Glp-1 Clinical Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485217","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512485217?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:12","pubTimestamp":1739977944,"startTime":"0","endTime":"0","summary":"BRIEF-Allurion To Raise Approximately $6.1 Million Of Gross Proceeds In Offering And Concurrent Private Placement To Advance Glp-1 Clinical PipelineFeb 19 (Reuters) - Allurion Technologies Inc ALUR.N:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA90PY78:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2512488480","title":"Allurion to sell 900,000 shares at $5.23 in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488480","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512488480?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:26","pubTimestamp":1739975171,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) announced that it has entered into a definitive securities purchase agreement with certain institutional investors for...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-to-sell-900000-shares-at-5-23-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-to-sell-900000-shares-at-5-23-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","ALUR"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":135,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-26","symbol":"ALUR","fiscalQuarterEnding":"2024/12","expectedEps":5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":7},{"market":"US","date":"2025-01-14","symbol":"ALUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736830800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-01-03","symbol":"ALUR","defaultRemindTime":1735914600000,"type":"split","dateTimestamp":1735880400000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2024-11-13","symbol":"ALUR","fiscalQuarterEnding":"2024/09","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2024-08-13","symbol":"ALUR","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALUR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1731643200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALUR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALUR","date":"2025-05-01","current":-0.540524,"percent":0.931034,"low":-4.394257,"twenty":-2.214533,"median":-1.239259,"eighty":-0.925907,"high":-0.306714,"avg":-1.569041,"sd":0.853906,"marketCap":14133611},"quantilePoints":[{"date":"2023-08-18","current":-2.037917,"twenty":-3.277082,"median":-2.839759,"eighty":-2.134151,"marketCap":133925760},{"date":"2023-08-25","current":-2.236047,"twenty":-2.898447,"median":-2.214819,"eighty":-2.105847,"marketCap":146946320},{"date":"2023-09-01","current":-2.816287,"twenty":-2.825676,"median":-2.250199,"eighty":-2.144058,"marketCap":185077960},{"date":"2023-09-08","current":-3.382375,"twenty":-3.27846,"median":-2.504939,"eighty":-2.172362,"marketCap":222279560},{"date":"2023-09-15","current":-3.86355,"twenty":-3.420586,"median":-2.839759,"eighty":-2.196421,"marketCap":253900920},{"date":"2023-09-22","current":-3.849398,"twenty":-3.840907,"median":-3.25425,"eighty":-2.214819,"marketCap":252970880},{"date":"2023-09-29","current":-2.986114,"twenty":-3.811187,"median":-3.133201,"eighty":-2.247369,"marketCap":196238440},{"date":"2023-10-06","current":-3.346995,"twenty":-3.729104,"median":-3.240853,"eighty":-2.275674,"marketCap":219954460},{"date":"2023-10-13","current":-3.12056,"twenty":-3.596073,"median":-3.233777,"eighty":-2.462482,"marketCap":205073820},{"date":"2023-10-20","current":-3.127636,"twenty":-3.515406,"median":-3.279772,"eighty":-2.734205,"marketCap":205538840},{"date":"2023-10-27","current":-3.118177,"twenty":-3.506915,"median":-3.247929,"eighty":-2.751188,"marketCap":204917216},{"date":"2023-11-03","current":-3.160601,"twenty":-3.44606,"median":-3.226701,"eighty":-2.804965,"marketCap":207705205},{"date":"2023-11-10","current":-3.026258,"twenty":-3.414926,"median":-3.168884,"eighty":-2.835065,"marketCap":198876572},{"date":"2023-11-17","current":-2.73411,"twenty":-3.405019,"median":-3.127636,"eighty":-2.780397,"marketCap":201708999},{"date":"2023-11-24","current":-2.498541,"twenty":-3.403604,"median":-3.118177,"eighty":-2.727355,"marketCap":184329841},{"date":"2023-12-01","current":-2.401948,"twenty":-3.390867,"median":-3.062787,"eighty":-2.517859,"marketCap":177203687},{"date":"2023-12-08","current":-2.131487,"twenty":-3.378129,"median":-3.042723,"eighty":-2.431569,"marketCap":157250457},{"date":"2023-12-15","current":-2.211861,"twenty":-3.366808,"median":-3.022722,"eighty":-2.28228,"marketCap":163180039},{"date":"2023-12-22","current":-2.284298,"twenty":-3.361147,"median":-2.969692,"eighty":-2.258787,"marketCap":168524069},{"date":"2023-12-29","current":-2.50951,"twenty":-3.358317,"median":-2.963751,"eighty":-2.253222,"marketCap":185139119},{"date":"2024-01-05","current":-2.174909,"twenty":-3.349825,"median":-2.941409,"eighty":-2.243761,"marketCap":160453903},{"date":"2024-01-12","current":-2.168474,"twenty":-3.341334,"median":-2.806389,"eighty":-2.214533,"marketCap":159979187},{"date":"2024-01-19","current":-2.039781,"twenty":-3.322936,"median":-2.772628,"eighty":-2.209949,"marketCap":150484873},{"date":"2024-01-26","current":-1.969,"twenty":-3.307368,"median":-2.73411,"eighty":-2.194213,"marketCap":145263001},{"date":"2024-02-02","current":-1.904654,"twenty":-3.300292,"median":-2.63612,"eighty":-2.172335,"marketCap":140515844},{"date":"2024-02-09","current":-1.904654,"twenty":-3.276234,"median":-2.50951,"eighty":-2.159537,"marketCap":140515844},{"date":"2024-02-16","current":-1.853177,"twenty":-3.245099,"median":-2.495321,"eighty":-2.128024,"marketCap":136718118},{"date":"2024-02-23","current":-1.769526,"twenty":-3.232789,"median":-2.427706,"eighty":-2.053281,"marketCap":130546814},{"date":"2024-03-01","current":-2.06552,"twenty":-3.229465,"median":-2.380817,"eighty":-2.023593,"marketCap":152383736},{"date":"2024-03-08","current":-1.737353,"twenty":-3.214402,"median":-2.288477,"eighty":-1.984444,"marketCap":128173236},{"date":"2024-03-15","current":-1.756657,"twenty":-3.18844,"median":-2.276159,"eighty":-1.962566,"marketCap":129597383},{"date":"2024-03-22","current":-1.183742,"twenty":-3.170541,"median":-2.265535,"eighty":-1.935541,"marketCap":95417853},{"date":"2024-03-28","current":-1.041238,"twenty":-3.155121,"median":-2.2545,"eighty":-1.923958,"marketCap":83931048},{"date":"2024-04-05","current":-1.828437,"twenty":-3.132088,"median":-2.24569,"eighty":-1.904654,"marketCap":147384785},{"date":"2024-04-12","current":-1.406946,"twenty":-3.126221,"median":-2.216746,"eighty":-1.837734,"marketCap":113409721},{"date":"2024-04-19","current":-1.21222,"twenty":-3.120083,"median":-2.207082,"eighty":-1.808134,"marketCap":97713423},{"date":"2024-04-26","current":-1.099317,"twenty":-3.115349,"median":-2.19744,"eighty":-1.781109,"marketCap":88612663},{"date":"2024-05-03","current":-1.307296,"twenty":-3.098849,"median":-2.193591,"eighty":-1.739927,"marketCap":105377221},{"date":"2024-05-10","current":-1.2657,"twenty":-3.071976,"median":-2.171691,"eighty":-1.682015,"marketCap":102024309},{"date":"2024-05-17","current":-1.557002,"twenty":-3.046521,"median":-2.16204,"eighty":-1.465452,"marketCap":89091650},{"date":"2024-05-24","current":-1.290455,"twenty":-3.042723,"median":-2.15369,"eighty":-1.416683,"marketCap":73839846},{"date":"2024-05-31","current":-1.265316,"twenty":-3.042723,"median":-2.134707,"eighty":-1.40101,"marketCap":72401407},{"date":"2024-06-07","current":-1.181521,"twenty":-3.033328,"median":-2.091259,"eighty":-1.366719,"marketCap":67606612},{"date":"2024-06-14","current":-1.164761,"twenty":-3.027672,"median":-2.073531,"eighty":-1.362568,"marketCap":66647653},{"date":"2024-06-21","current":-2.178691,"twenty":-3.022015,"median":-2.06552,"eighty":-1.337381,"marketCap":124664675},{"date":"2024-06-28","current":-1.089345,"twenty":-3.019187,"median":-2.039781,"eighty":-1.323836,"marketCap":62332337},{"date":"2024-07-05","current":-1.371978,"twenty":-2.992729,"median":-2.037917,"eighty":-1.303928,"marketCap":78504608},{"date":"2024-07-12","current":-1.16835,"twenty":-2.972976,"median":-1.988304,"eighty":-1.275208,"marketCap":66852994},{"date":"2024-07-15","current":-1.190818,"twenty":-2.969692,"median":-1.988304,"eighty":-1.2657,"marketCap":68138628},{"date":"2024-08-02","current":-0.998715,"twenty":-2.969692,"median":-1.985087,"eighty":-1.265393,"marketCap":57146453},{"date":"2024-08-09","current":-0.877274,"twenty":-2.967315,"median":-1.969,"eighty":-1.25853,"marketCap":50197599},{"date":"2024-08-16","current":-1.15974,"twenty":-2.954529,"median":-1.959348,"eighty":-1.213876,"marketCap":43358023},{"date":"2024-08-23","current":-1.101563,"twenty":-2.921079,"median":-1.943262,"eighty":-1.19517,"marketCap":41183045},{"date":"2024-08-30","current":-1.161805,"twenty":-2.835065,"median":-1.923958,"eighty":-1.185157,"marketCap":43435242},{"date":"2024-09-06","current":-1.084351,"twenty":-2.816287,"median":-1.92074,"eighty":-1.179584,"marketCap":40539560},{"date":"2024-09-13","current":-1.084351,"twenty":-2.796492,"median":-1.904654,"eighty":-1.168346,"marketCap":40539560},{"date":"2024-09-20","current":-1.084351,"twenty":-2.785576,"median":-1.888568,"eighty":-1.164682,"marketCap":40539560},{"date":"2024-09-27","current":-1.106211,"twenty":-2.759679,"median":-1.833873,"eighty":-1.15733,"marketCap":41356786},{"date":"2024-10-04","current":-1.192959,"twenty":-2.743243,"median":-1.818285,"eighty":-1.152798,"marketCap":44599950},{"date":"2024-10-11","current":-1.213441,"twenty":-2.73411,"median":-1.808134,"eighty":-1.157116,"marketCap":45365698},{"date":"2024-10-18","current":-1.213441,"twenty":-2.717222,"median":-1.78883,"eighty":-1.15733,"marketCap":45365698},{"date":"2024-10-25","current":-1.239259,"twenty":-2.664226,"median":-1.766276,"eighty":-1.15974,"marketCap":46330925},{"date":"2024-10-31","current":-1.257286,"twenty":-2.619256,"median":-1.750223,"eighty":-1.161392,"marketCap":47004885},{"date":"2024-11-08","current":-1.211817,"twenty":-2.546193,"median":-1.708398,"eighty":-1.162907,"marketCap":45304982},{"date":"2024-11-15","current":-1.041785,"twenty":-2.513756,"median":-1.679441,"eighty":-1.162907,"marketCap":25794606},{"date":"2024-11-22","current":-1.33062,"twenty":-2.500735,"median":-1.519332,"eighty":-1.159258,"marketCap":32946161},{"date":"2024-11-29","current":-1.210798,"twenty":-2.498541,"median":-1.432311,"eighty":-1.160979,"marketCap":29979349},{"date":"2024-12-06","current":-1.158542,"twenty":-2.494677,"median":-1.416149,"eighty":-1.158057,"marketCap":28685503},{"date":"2024-12-13","current":-1.100233,"twenty":-2.465055,"median":-1.403978,"eighty":-1.157207,"marketCap":27241761},{"date":"2024-12-20","current":-0.891848,"twenty":-2.423842,"median":-1.389137,"eighty":-1.141274,"marketCap":22082157},{"date":"2024-12-27","current":-1.379672,"twenty":-2.405811,"median":-1.379672,"eighty":-1.141153,"marketCap":34160679},{"date":"2025-01-03","current":-1.329328,"twenty":-2.397722,"median":-1.379672,"eighty":-1.141924,"marketCap":32914159},{"date":"2025-01-10","current":-0.922755,"twenty":-2.380817,"median":-1.371978,"eighty":-1.134971,"marketCap":22847412},{"date":"2025-01-17","current":-0.397651,"twenty":-2.356871,"median":-1.368256,"eighty":-1.128909,"marketCap":9845846},{"date":"2025-01-24","current":-0.387318,"twenty":-2.305499,"median":-1.365871,"eighty":-1.115961,"marketCap":9589993},{"date":"2025-01-31","current":-0.741922,"twenty":-2.28597,"median":-1.362395,"eighty":-1.105522,"marketCap":18369979},{"date":"2025-02-07","current":-0.9014,"twenty":-2.284298,"median":-1.346004,"eighty":-1.100998,"marketCap":22318666},{"date":"2025-02-14","current":-0.72528,"twenty":-2.277787,"median":-1.332353,"eighty":-1.088963,"marketCap":17957942},{"date":"2025-02-21","current":-0.499237,"twenty":-2.273321,"median":-1.329328,"eighty":-1.084351,"marketCap":12361107},{"date":"2025-02-28","current":-0.45486,"twenty":-2.268602,"median":-1.323028,"eighty":-1.07664,"marketCap":11262342},{"date":"2025-03-07","current":-0.61631,"twenty":-2.265298,"median":-1.307296,"eighty":-1.070202,"marketCap":15259845},{"date":"2025-03-14","current":-0.709618,"twenty":-2.260876,"median":-1.294624,"eighty":-1.057554,"marketCap":17570139},{"date":"2025-03-21","current":-0.663086,"twenty":-2.253688,"median":-1.277641,"eighty":-1.040296,"marketCap":16417999},{"date":"2025-03-28","current":-0.881245,"twenty":-2.24759,"median":-1.273909,"eighty":-1.027852,"marketCap":23042806},{"date":"2025-04-04","current":-0.711575,"twenty":-2.24569,"median":-1.265316,"eighty":-1.011628,"marketCap":18606272},{"date":"2025-04-11","current":-0.538243,"twenty":-2.239904,"median":-1.262537,"eighty":-1.001498,"marketCap":14073975},{"date":"2025-04-17","current":-0.513155,"twenty":-2.228945,"median":-1.257754,"eighty":-0.995301,"marketCap":13417985},{"date":"2025-04-25","current":-0.531401,"twenty":-2.217055,"median":-1.242342,"eighty":-0.961361,"marketCap":13895069},{"date":"2025-05-01","current":-0.540524,"twenty":-2.214533,"median":-1.239259,"eighty":-0.925907,"marketCap":14133611}],"updateTime":1746179013485}}}